CTS communications distributed on July 6th and July 20th. In working with Grifols on the availability of ZIKV test reagents, CTS projects that you should be prepared to convert from a ZIKV clinical trial test to a licensed test as early as October 29, 2018. The communication includes a quick survey link and instructions to register for the upcoming webinar.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...